These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16970596)

  • 1. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
    Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
    J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
    Cross TJ; Calvaruso V; Foxton MR; Manousou P; Quaglia A; Grillo F; Dhillon AP; Nolan J; Chang TP; O'Grady J; Heneghan MA; O'Beirne JP; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Sep; 17(9):640-9. PubMed ID: 19922441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
    Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
    J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.
    Mehta P; Ploutz-Snyder R; Nandi J; Rawlins SR; Sanderson SO; Levine RA
    Am J Gastroenterol; 2008 Apr; 103(4):928-36. PubMed ID: 18371145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index.
    Sud A; Hui JM; Farrell GC; Bandara P; Kench JG; Fung C; Lin R; Samarasinghe D; Liddle C; McCaughan GW; George J
    Hepatology; 2004 May; 39(5):1239-47. PubMed ID: 15122752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.